Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) will be presenting at and attending several major conferences in September, October, and November 2024, showcasing its progress in cancer immunotherapy development. Key events include the ADC & Radiopharmaceuticals Summit in Boston (September 9-10), ESMO Congress in Barcelona (September 13-17), and the Vaccines & Immunotherapies Online Symposium (September 26). Additionally, Scancell will participate in the Festival of Biologics in Basel (October 15-17) and the PEGS Europe conference in Barcelona (November 5-7). For more information click here.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com